| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1805 | 2023 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1208 | 2022 |
| Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease … ML Ferreira, K De Luca, LM Haile, JD Steinmetz, GT Culbreth, M Cross, ... The Lancet Rheumatology 5 (6), e316-e329, 2023 | 718 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 653 | 2022 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 464 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 456 | 2024 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 369 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 262 | 2024 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 178 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 168 | 2022 |
| Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons M Majidinia, M Mirza‐Aghazadeh‐Attari, M Rahimi, A Mihanfar, ... IUBMB life 72 (5), 855-871, 2020 | 164 | 2020 |
| The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of … AF Awedew, H Han, B Abbasi, M Abbasi-Kangevari, MB Ahmed, ... The Lancet Healthy Longevity 3 (11), e754-e776, 2022 | 151 | 2022 |
| 53BP1: A key player of DNA damage response with critical functions in cancer M Mirza-Aghazadeh-Attari, A Mohammadzadeh, B Yousefi, A Mihanfar, ... DNA repair 73, 110-119, 2019 | 146 | 2019 |
| Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy M Mirza-Aghazadeh-Attari, EM Ekrami, SAM Aghdas, A Mihanfar, S Hallaj, ... Life sciences 255, 117481, 2020 | 97 | 2020 |
| DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications M Mirza-Aghazadeh-Attari, SG Darband, M Kaviani, A Mihanfar, JA Attari, ... DNA repair 69, 34-52, 2018 | 78 | 2018 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 77 | 2024 |
| Crosstalk between Phosphoinositide 3‐kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer A Karimian, SM Mir, H Parsian, S Refieyan, M Mirza‐Aghazadeh‐Attari, ... Journal of cellular biochemistry 120 (6), 10248-10272, 2019 | 77 | 2019 |
| Exosomes: natural nanoparticles as bio shuttles for RNAi delivery SG Darband, M Mirza-Aghazadeh-Attari, M Kaviani, A Mihanfar, ... Journal of Controlled Release 289, 158-170, 2018 | 71 | 2018 |
| The risk factors associated with MERS-CoV patient fatality: A global survey J Ahmadzadeh, K Mobaraki, SJ Mousavi, J Aghazadeh-Attari, ... Diagnostic microbiology and infectious disease 96 (3), 114876, 2020 | 63 | 2020 |
| In vitro and in vivo anticancer effects of syringic acid on colorectal cancer: Possible mechanistic view A Mihanfar, SG Darband, S Sadighparvar, M Kaviani, ... Chemico-Biological Interactions 337, 109337, 2021 | 55 | 2021 |
